(S)-(2-Hydroxymethyl)morpholine hydrochloride, 95.0%, 25g

tert-butyl 3-(aminomethyl)-2H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxylate, 97%, 250mg

Ethyl 2-Aminoisonicotinate, 97.0%, 1g

2-Fluoro-4-(methoxymethoxy)-benzoic acid, 98%, 1g

Flacon à col étroit 301, 2000 ml, 28 mm, 1 Pièce

5-Bromo-8-hydroxyquinoline-7-carboxylic acid, 95%, 100mg

ETHYL 8-BROMOIMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLATE, 95.0%, 250mg

5-Methoxy-2-nitrobenzaldehyde, 98.0%, 5g

2-(3-Methoxyphenyl)-2-methylpropanenitrile, 97.0%, 5g

(S)-2-((S)-2-Amino-3-(1H-indol-3-yl)propanamido)-4-(trimethylsilyl)butanoic acid hydrochloride, 97%, 5mg

Pyrimidine-4-boronic acid, 95.0%, 100mg

2-(3-Hydroxyphenoxy)acetonitrile, 98%, 250mg

2-(2-(2-(2-Hydroxyethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 98.0%, 1g